Intercept Pharmaceuticals Insiders
Intercept Pharmaceuticals employs about 341 people. The company is managed by 10 executives with a total tenure of roughly 16 years, averaging almost 1.0 years of service per executive, having 34.1 employees per reported executive. Breaking down Intercept Pharmaceuticals' management performance can provide insight into the firm performance.
| Jerome Durso CEO CEO Pres |
Intercept |
Intercept Pharmaceuticals Management Team Effectiveness
The company has return on total asset (ROA) of (0.0723) % which means that it has lost $0.0723 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6402) %, meaning that it created substantial loss on money invested by shareholders. Intercept Pharmaceuticals' management efficiency ratios could be used to measure how well Intercept Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.Intercept Pharmaceuticals Workforce Comparison
Intercept Pharmaceuticals is rated fifth overall in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 4,944. Intercept Pharmaceuticals holds roughly 341 in number of employees claiming about 7% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.19) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.02 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.02. Intercept Pharmaceuticals Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Intercept Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on Intercept Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Intercept Pharmaceuticals insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Christian Weyer over a year ago Payment of 357 shares by Christian Weyer of Intercept Pharmaceuticals subject to Rule 16b-3 | ||
Christian Weyer over a year ago Payment of tradable shares by Christian Weyer of Intercept Pharmaceuticals subject to Rule 16b-3 |
Intercept Pharmaceuticals Notable Stakeholders
An Intercept Pharmaceuticals stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Intercept Pharmaceuticals often face trade-offs trying to please all of them. Intercept Pharmaceuticals' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Intercept Pharmaceuticals' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Jerome Durso | CEO Pres | Profile | |
| Linda Richardson | Ex Officer | Profile | |
| Andrew Saik | Chief Officer | Profile | |
| David Ford | Chief Human Resource Officer | Profile | |
| Mark MD | Advisor Founder | Profile | |
| Jared JD | G Counsel | Profile | |
| Rocco Venezia | Chief Treasurer | Profile | |
| Paul Nitschmann | VP Affairs | Profile | |
| Nareg Sagherian | Ex Relations | Profile | |
| MD MPH | Pres Officer | Profile |
Intercept Pharmaceuticals Workforce Analysis
Traditionally, organizations such as Intercept Pharmaceuticals use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Intercept Pharmaceuticals within its industry.Intercept Pharmaceuticals Manpower Efficiency
Return on Intercept Pharmaceuticals Manpower
| Revenue Per Employee | 837.9K | |
| Revenue Per Executive | 28.6M | |
| Net Loss Per Employee | 512.8K | |
| Net Loss Per Executive | 17.5M | |
| Working Capital Per Employee | 909.2K | |
| Working Capital Per Executive | 31M |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Consideration for investing in Intercept Stock
If you are still planning to invest in Intercept Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Intercept Pharmaceuticals' history and understand the potential risks before investing.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |